>>> US Research Calls I

Research Calls I
  • Upgrades:
    • Adecoagro (AGRO) upgraded to Equal Weight from Underweight at Morgan Stanley, tgt $13
    • Align Technology (ALGN) upgraded to Overweight from Equal Weight at Barclays, tgt $200
    • Alpine Income Property (PINE) upgraded to Strong Buy from Outperform at Raymond James, tgt $22
    • Canadian Solar (CSIQ) upgraded to Neutral from Underperform at Mizuho, tgt $19
    • Dover (DOV) upgraded to Overweight from Equal Weight at Wells Fargo, tgt $230
    • Essential Properties Realty Trust (EPRT) upgraded to Strong Buy from Outperform at Raymond James, tgt $37
    • Ichor Holdings (ICHR) upgraded to Buy from Hold at Stifel, tgt $55
    • LatAm Airlines Group (LTM) upgraded to Buy from Neutral at Citigroup, tgt $58
    • Lemonade (LMND) upgraded to Overweight from Equal Weight at Morgan Stanley, tgt $85
    • MSCI (MSCI) upgraded to Strong Buy from Outperform at Raymond James, tgt $710
    • Neste (NTOIY) upgraded to Overweight from Equal Weight at Barclays
    • Tandem Diabetes Care (TNDM) upgraded to Overweight from Neutral at Piper Sandler, tgt $33
    • Target Hospitality (TH) upgraded to Outperform from Perform at Oppenheimer, tgt $11
    • W. P. Carey (WPC) upgraded to Outperform from Market Perform at Raymond James, tgt $76
  • Downgrades:
    • CONMED (CNMD) downgraded to Neutral from Overweight at Piper Sandler, tgt $39
    • DraftKings (DKNG) downgraded to Hold from Buy at Argus
    • Eli Lilly (LLY) downgraded to Reduce from Hold at HSBC, tgt $850
    • EPR Properties (EPR) downgraded to Outperform from Strong Buy at Raymond James, tgt $60
    • Li Auto (LI) downgraded to Neutral from Buy at Goldman, tgt $19
    • MarketAxess (MKTX) downgraded to Hold from Buy at Argus
    • National Retail Properties (NNN) downgraded to Market Perform from Outperform at Raymond James
    • Netstreit (NTST) downgraded to Outperform from Strong Buy at Raymond James, tgt $22
    • PlayStudios (MYPS) downgraded to Hold from Speculative Buy at Benchmark
    • Sony (SONY) downgraded to Market Perform from Outperform at Bernstein, tgt $22
  • Others:
    • Arthur J. Gallagher (AJG) resumed with an Outperform at RBC Capital, tgt $260
    • Ingredion (INGR) initiated with a Buy at Benchmark, tgt $130
    • Navan (NAVN) initiated with an Outperform at BMO Capital, tgt $13
    • Nektar Therapeutics (NKTR) initiated with a Buy at TD Cowen
    • PTC (PTC) reinstated with an Overweight at Barclays, tgt $180
    • QuinStreet (QNST) initiated with an Outperform at Northland, tgt $17
    • Tenax Therapeutics (TENX) initiated with an Overweight at Cantor Fitzgerald, tgt $35
    • TIC Solutions (TIC) initiated with a Buy at Roth Capital, tgt $10